PSYC (PSYC) Cash, Cash Equivalents, Marketable Securities : $0.31 Mil (As of Sep. 2023)

View and export this data going back to 2007. Start your Free Trial

What is PSYC Cash, Cash Equivalents, Marketable Securities?

PSYC's quarterly cash, cash equivalents, marketable securities declined from Jun. 2017 ($0.01 Mil) to Sep. 2022 ($0.00 Mil) but then increased from Sep. 2022 ($0.00 Mil) to Sep. 2023 ($0.31 Mil).

PSYC's annual cash, cash equivalents, marketable securities increased from Dec. 2013 ($0.14 Mil) to Dec. 2014 ($0.15 Mil) but then declined from Dec. 2014 ($0.15 Mil) to Dec. 2016 ($0.04 Mil).

PSYC Cash, Cash Equivalents, Marketable Securities Historical Data

The historical data trend for PSYC's Cash, Cash Equivalents, Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PSYC Cash, Cash Equivalents, Marketable Securities Chart

PSYC Annual Data

Trend

Dec11

Dec12

Dec13

Dec14

Dec16

Cash, Cash Equivalents, Marketable Securities

0.06

0.14

0.15

0.04

PSYC Quarterly Data
	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Dec14	Mar15	Jun15	Sep15	Mar16	Jun16	Sep16	Dec16	Jun17	Sep22	Sep23
Cash, Cash Equivalents, Marketable Securities	Get a 7-Day Free Trial															0.01	0.04	0.01	-	0.31

PSYC Cash, Cash Equivalents, Marketable Securities Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

PSYC (OTCPK:PSYC) Cash, Cash Equivalents, Marketable Securities Explanation

Marketable securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

PSYC Cash, Cash Equivalents, Marketable Securities Related Terms

Thank you for viewing the detailed overview of PSYC's Cash, Cash Equivalents, Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

PSYC (PSYC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Communication Services » Media - Diversified » PSYC Corp (OTCPK:PSYC) » Definitions » Cash, Cash Equivalents, Marketable Securities

Comparable Companies

Traded in Other Exchanges

N/A

Address

2881 South Valley View Boulevard, Suite 9, Las Vegas, NV, USA, 89102

Website

https://www.psyccorporation.com

PSYC Corp is a media-focused company serving the expanding industry and community of medicinal psychedelics. Through its media platform, Psychedelic Spotlight, the company has positioned itself right at the very core of the psychedelics renaissance. Technical420 is also one such platform that provides information and analysis on public and private companies. These platforms provide the Company with an opportunity to dominate the intersection of cannabis and psychedelics as a media leader. Along with its subsidiary, the group offers public relations and media-focused services to companies within the medicinal psychedelics industry and other niche industries that includes cannabis, health, and wellness, and sports, among others.